Please use this identifier to cite or link to this item: http://ir.mu.ac.ke:8080/jspui/handle/123456789/6095
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLaktabai, Jeremiah-
dc.date.accessioned2022-03-17T07:16:33Z-
dc.date.available2022-03-17T07:16:33Z-
dc.date.issued2018-
dc.identifier.urihttp://ir.mu.ac.ke:8080/jspui/handle/123456789/6095-
dc.description.abstractThe objective of this experiment is to identify the combination of RDT and conditional (diagnosisdependent) ACT subsidies that maximize the percent of clients receiving an RDT. We will test two different RDT price levels and two discounted ACT price levels in a factorial design. ACT discounts are conditional on a positive RDT result. The primary outcome measure is the decision to purchase an RDT before purchasing a drug. Secondary outcome measures are: Decision to purchase an ACT stratified by testing status: (a.) Positive mRDT (b.) Negative mRDT (c.) No malaria test. All outcomes will be measured by interviewing the participant after they make their decision about whether to be tested and which medicines to purchase.en_US
dc.description.sponsorshipNIH-NIAIDen_US
dc.language.isoenen_US
dc.publisherMoi Universityen_US
dc.subjectMalariaen_US
dc.subjectDiagnosticen_US
dc.subjectTestingen_US
dc.titleA randomized experiment of malaria diagnostic testing and conditional subsidies to target ACTs in the retail sector: the TESTsmART trial AIM 1en_US
dc.typeArticleen_US
Appears in Collections:School of Medicine

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.